Healthcare-associated vs. hospital-acquired Staphylococcus aureus bacteremia

International Journal of Infectious Diseases

Volumn 16, Issue 6, 2012, Pages

  Bishara, Jihad ^a   Goldberg, Elad ^a   Leibovici, Leonard ^a   Samra, Zmira ^a   Shaked, Hila ^a   Mansur, Nariman ^a   Paul, Mical ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Healthcare; Mortality; MRSA; Nosocomial; Staphylococcus aureus

Indexed keywords

BETA LACTAM ANTIBIOTIC; CREATININE; GLUCOSE; QUINOLONE; SERUM ALBUMIN; UREA;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANTIBIOTIC THERAPY; ARTICLE; BODY TEMPERATURE; BONE AND JOINT INFECTIONS; CATHETER INFECTION; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; CEREBROVASCULAR DISEASE; CHEMOTHERAPY; CHRONIC KIDNEY FAILURE; CHRONIC LUNG DISEASE; CLINICAL FEATURE; COMORBIDITY; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DEBRIDEMENT; DECUBITUS; DEMENTIA; DIABETES MELLITUS; ENDOCARDITIS; FEMALE; FOREIGN BODY; GLUCOSE BLOOD LEVEL; HEALTHCARE ASSOCIATED INFECTION; HEART FAILURE; HEMODIALYSIS; HOSPITAL INFECTION; HUMAN; INFECTION RISK; LENGTH OF STAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; NONHUMAN; PNEUMONIA; PREVALENCE; RECURRENT INFECTION; RETROSPECTIVE STUDY; SEPTIC SHOCK; SOFT TISSUE INFECTION; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS AUREUS; SURGICAL INFECTION; SURVIVAL; THROMBOCYTE COUNT; UREA BLOOD LEVEL; URINARY CATHETER; VALVULAR HEART DISEASE; WOUND DRAINAGE;

BACTEREMIA; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; HOSPITALIZATION; HUMANS; ISRAEL; PREVALENCE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURVIVAL RATE;

EID: 84860382381     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2012.02.009     Document Type: Article

References (26)

1. Friedman N.D., Kaye K.S., Stout J.E., McGarry S.A., Trivette S.L., Briggs J.P. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002, 137:791-797.
2. Shorr A.F., Tabak Y.P., Killian A.D., Gupta V., Liu L.Z., Kollef M.H. Healthcare-associated bloodstream infection: a distinct entity? Insights from a large U. S. database. Crit Care Med 2006, 34:2588-2595.
3. Siegman-Igra Y., Fourer B., Orni-Wasserlauf R., Golan Y., Noy A., Schwartz D., Giladi M. Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. Clin Infect Dis 2002, 34:1431-1439.
4. Cosgrove S.E., Sakoulas G., Perencevich E.N., Schwaber M.J., Karchmer A.W., Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003, 36:53-59.
5. Kallen A.J., Mu Y., Bulens S., Reingold A., Petit S., Gershman K. Health care-associated invasive MRSA infections, 2005-2008. JAMA 2005, 304:641-648.
6. Lesens O., Hansmann Y., Brannigan E., Hopkins S., Meyer P., O'Connel B. Healthcare-associated Staphylococcus aureus bacteremia and the risk for methicillin resistance: is the Centers for Disease Control and Prevention definition for community-acquired bacteremia still appropriate?. Infect Control Hosp Epidemiol 2005, 26:204-209.
7. Morin C.A., Hadler J.L. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J Infect Dis 2001, 184:1029-1034.
8. Tacconelli E., Venkataraman L., De Girolami P.C., Dagata E.M. Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare-associated strains. J Antimicrob Chemother 2004, 53:474-479.
9. Tambyah P.A., Habib A.G., Ng T.M., Goh H., Kumarasinghe G. Community-acquired methicillin-resistant Staphylococcus aureus infection in Singapore is usually "healthcare associated" Infect Control Hosp Epidemiol 2003, 24:436-438.
10. Naimi T.S., LeDell K.H., Como-Sabetti K., Borchardt S.M., Boxrud D.J., Etienne J. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003, 290:2976-2984.
11. Gafter-Gvili A., Mansur N., Bivas A., Zemer-Wassercug N., Bishara J., Leibovici L., Paul M. Thrombocytopenia in Staphylococcus aureus bacteremia: risk factors and prognostic importance. Mayo Clin Proc 2011, 86:389-396.
12. Paul M., Kariv G., Goldberg E., Raskin M., Shaked H., Hazzan R. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 2010, 65:2658-2665.
13. Paul M., Zemer-Wassercug N., Talker O., Lishtzinsky Y., Lev B., Samra Z. Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?. Clin Microbiol Infect 2011, 17:1581-1586.
14. van Buuren S. Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 2007, 16:219-242.
15. Rodriguez-Bano J., Lopez-Prieto M.D., Portillo M.M., Retamar P., Natera C., Nuno E., et al. Epidemiology and clinical features of community-acquired, healthcare associated and nosocomial bloodstream infections in tertiary and community hospitals. Clin Microbiol Infect 2010, 16:1408-1413.
16. Son J.S., Song J.H., Ko K.S., Yeom J.S., Ki H.K., Kim S.W. Bloodstream infections and clinical significance of healthcare-associated bacteremia: a multicenter surveillance study in Korean hospitals. J Korean Med Sci 2010, 25:992-998.
17. Marschall J., Fraser V.J., Doherty J., Warren D.K. Between community and hospital: healthcare-associated Gram-negative bacteremia among hospitalized patients. Infect Control Hosp Epidemiol 2009, 30:1050-1056.
18. Kollef M.H., Shorr A., Tabak Y.P., Gupta V., Liu L.Z., Johannes R.S. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005, 128:3854-3862.
19. Leibovici L., Samra Z., Konigsberger H., Drucker M., Ashkenazi S., Pitlik S.D. Long-term survival following bacteremia or fungemia. JAMA 1995, 274:807-812.
20. Heath Protection Agency 2009. Healthcare-associated infections in England: 2008-2009. UK: HPA; 2009. Available at: (accessed August 28, 2010). http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1252326222452.
21. European Antimicrobial Resistance Surveillance System (EARSS). Annual reports. EARRSS; EUROSURVEI L LANCE 2008;1:488-740. Available at: (accessed August 30, 2010). http://www.eurosurveillance.org/.
22. Bassetti M, Trecarichi EM, Mesini A, Spanu T, Giacobbe DR, Rossi M. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia. Clin Microbiol Infect 2011.
23. El Atrouni W.I., Knoll B.M., Lahr B.D., Eckel-Passow J.E., Sia I.G., Baddour L.M. Temporal trends in the incidence of Staphylococcus aureus bacteremia in Olmsted County, Minnesota, 1998 to 2005: a population-based study. Clin Infect Dis 2009, 49:e130-e138.
24. Fowler V.G., Olsen M.K., Corey G.R., Woods C.W., Cabell C.H., Reller L.B. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 2003, 163:2066-2072.
25. Nickerson E.K., Hongsuwan M., Limmathurotsakul D., Wuthiekanun V., Shah K.R., Srisomang P. Staphylococcus aureus bacteraemia in a tropical setting: patient outcome and impact of antibiotic resistance. PLoS One 2009, 4:e4308.
26. Graffunder E.M., Venezia R.A. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 2002, 49:999-1005.